Anatomy of a value proposition for laboratory medicine

2014 ◽  
Vol 436 ◽  
pp. 104-111 ◽  
Author(s):  
Christopher P. Price ◽  
Andrew St John
2020 ◽  
Vol 26 (6) ◽  
pp. 1-8
Author(s):  
Christopher P Price ◽  
Patrick McGinley ◽  
Andrew St John

Procuring and managing diagnostic services, such as laboratory medicine, is generally based on cost and activity. Improving productivity of laboratory services therefore tends to focus on reducing the cost per test. However, this approach fails to recognise the impact of the test result on the other stakeholders involved in delivering care to the patient across the care pathway. Any assessment of the return on investment from a diagnostic service therefore needs to be undertaken together with a value proposition established for the service. This will enable the clinical, process and economic impact for all stakeholders to be assessed, which can then be used to develop an implementation plan that ensures the expectations of all stakeholders can be addressed.


2020 ◽  
Vol 5 (5) ◽  
pp. 1027-1037
Author(s):  
Luis Enrique Cortés-Hernández ◽  
Zahra Eslami-S ◽  
Catherine Alix-Panabières

Abstract The long-term effects of cancer on patient quality of life and its economic burden are important issues that need to be addressed. Therefore, it is critical to assess patient priorities and investigate the value proposition of clinical tests in this field. The minimally invasive liquid biopsy has attracted much attention because it allows serial sampling during cancer progression, and provides valuable biological information on the tumor biology and treatment response through the analysis of analytes in the blood, such as circulating tumor cells (CTCs). To introduce CTC analysis in daily clinical practice, it is still necessary to firmly establish its clinical benefits and extra value for clinical decision-making. A laboratory medicine value proposition of CTC medical applications can help to address these issues. In this review, we discuss the current evidence for a value proposition of CTC detection, isolation, and characterization using the available technologies, and we summarize the unmet requirements for the full integration of CTCs in the care pathway.


2015 ◽  
Vol 77 ◽  
pp. 29-34 ◽  
Author(s):  
P.C. Beukes ◽  
S. Mccarthy ◽  
C.M. Wims ◽  
A.J. Romera

Paddock selection is an important component of grazing management and is based on either some estimate of pasture mass (cover) or the interval since last grazing for each paddock. Obtaining estimates of cover to guide grazing management can be a time consuming task. A value proposition could assist farmers in deciding whether to invest resources in obtaining such information. A farm-scale simulation exercise was designed to estimate the effect of three levels of knowledge of individual paddock cover on profitability: 1) "perfect knowledge", where cover per paddock is known with perfect accuracy, 2) "imperfect knowledge", where cover per paddock is estimated with an average error of 15%, 3) "low knowledge", where cover is not known, and paddocks are selected based on longest time since last grazing. Grazing management based on imperfect knowledge increased farm operating profit by approximately $385/ha compared with low knowledge, while perfect knowledge added a further $140/ha. The main driver of these results is the level of accuracy in daily feed allocation, which increases with improving knowledge of pasture availability. This allows feed supply and demand to be better matched, resulting in less incidence of under- and over-feeding, higher milk production, and more optimal post-grazing residuals to maximise pasture regrowth. Keywords: modelling, paddock selection, pasture cover


Animals ◽  
2021 ◽  
Vol 11 (1) ◽  
pp. 91
Author(s):  
Jaime Manning ◽  
Deborah Power ◽  
Amy Cosby

The five freedoms and, more recently, the five domains of animal welfare provide internationally recognised frameworks to evaluate animal welfare practices which recognise both the physical and mental wellbeing needs of animals, providing a balanced view of their ability to cope in their environment. Whilst there are many techniques to measure animal welfare, the challenge lies with how best to align these with future changes in definitions and expectations, advances in science, legislative requirements, and technology improvements. Furthermore, enforcement of current animal welfare legislation in relation to livestock in Australia and the reliance on self-audits for accreditation schemes, challenges our ability to objectively measure animal welfare. On-animal sensors have enormous potential to address animal welfare concerns and assist with legislative compliance, through continuous measurement and monitoring of an animal’s behavioural state and location being reflective of their wellbeing. As reliable animal welfare measures evolve and the cost of on-animal sensors reduce, technology adoption will increase as the benefits across the supply chain are realised. Future adoption of on-animal sensors by producers will primarily depend on a value proposition for their business being clear; algorithm development to ensure measures are valid and reliable; increases in producer knowledge, willingness, and trust in data governance; and improvements in data transmission and connectivity.


2018 ◽  
Vol 35 (3) ◽  
pp. 122-127 ◽  
Author(s):  
Jestine Philip ◽  
Manjula S Salimath

The rapidly increasing significance of cyberspace and the corresponding use of new cyberspace technologies are seen in private, public, and nonprofit organizations across the globe. However, along with the abundant organizational advantages of operating in cyberspace, it also creates vulnerabilities such as the possibility of cyberattacks which can erode value. In light of these current realities, we propose a value creation agenda for organizations that operate in cyberspace. We suggest that when organizations effectively manage the risks associated with cyberattacks and continue to attain benefits from cyberspace, there is a positive contribution toward organizational value.


2019 ◽  
Vol 109 (04) ◽  
pp. 294-301
Author(s):  
R. E. Geitner ◽  
T. Bauernhansl

Die fortschreitende Digitalisierung führt zu neuen und konvergierenden Produkt- und Dienstleistungen und effizienteren Prozessen. In Verbindung mit einem Wandel der Bedürfnisse führt sie darüber hinaus auch zu einem veränderten Nutzerverhalten und Nutzenverständnis der Kunden. Zur flexiblen und schnellen Umsetzung von passgenau individualisierten, oft branchenübergreifenden Wertangeboten und der Absicherung des Kundenzugangs wird es zukünftig wettbewerbsentscheidend sein, sich im richtigen Business Ecosystem – also der Gruppe von Akteuren die interagieren müssen, um ein entsprechendes Wertangebot zu realisieren und den entsprechenden Kundenzugang haben – zu bewegen und dieses mitzugestalten. Der Beitrag beschreibt das grundsätzliche Vorgehen zur Identifizierung und Auswahl relevanter Business Ecosystems sowie deren strategische und operative Einbindung in ein Unternehmen.   The ongoing digitization leads to new and converging product benefits and more efficient processes. In connection with a change in needs it also leads to a change in user behaviour and understanding of the benefits for customers. For the flexible and fast implementation of customized, individualized, often cross-industry value propositions and the safeguarding of access to customers, it will be crucial in the future to act and help to shape the relevant business ecosystems (group of actors that need to interact in order to realize a value proposition or to have access to customers). The article describes the basic procedure for identifying and selecting relevant business ecosystems and their strategic and operational integration into a company.


2019 ◽  
Vol 489 ◽  
pp. 89-95
Author(s):  
V. Scharnhorst ◽  
E.M.H. Schmitz ◽  
D. van de Kerkhof ◽  
L.J.J. Derijks ◽  
M.A.C. Broeren

2020 ◽  
Author(s):  
Sebastian Fuller ◽  
Emma Harding-Esch

IntroductionSexually Transmitted Infections (STIs), including Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT), continue to be a global health problem, with the majority of the disease burden in Low and Middle Income Countries. This could in part be addressed through increased access to rapid point-of-care-tests (POCTs) for infection detection and appropriate clinical management. Guidelines and criteria for the development of STI POCTs have been established, and several POCTs for CT and NG have been brought to market. Yet even those diagnostics with good evidence of clinical effectiveness often fail to be implemented and adopted into routine care. Here we review the current literature for test development and implementation alongside studies of how the Cepheid CT/NG GeneXpert POCT has been utilised in different healthcare settings, to develop a value proposition for CT/NG POCT adoption.MethodsWe review whether the Cepheid CT/NG GeneXpert fulfil the (RE)ASSURED and Target Product Profile (TPP) criteria, and present published literature reporting on the test’s implementation, to demonstrate its range of values in different settings and to a variety of stakeholders. This information is then applied to the value proposition for laboratory medicine, to form the basis of a value proposition for a CT/NG POCT. ResultsThe Cepheid CT/NG GeneXpert did not fulfil all (RE)ASSURED or TPP criteria, however, studies of test implementation showed multiple stakeholder values for the use of the test across various healthcare settings and geographic locations. The majority of values identified were setting specific. Sexual health services and outreach services had the least overlap in values, whereas General Practice and other non-sexual health specialist services served as a “bridge” between the two.ConclusionWe recommend that those wishing to improve CT/NG diagnosis be supported to identify the values most relevant to their settings and context, and prioritise implementation of those tests most closely aligned with those values.


Author(s):  
Carlos Lemos

Laboratory medicine has a unique capability to evaluate the correct management of a medical test, its results, and the decisions it can determine. Therefore, laboratory medicine should try to improve patient outcomes, while improving quality and productivity, so that innovation in healthcare may proceed. Innovation in laboratory medicine demands an adequate identification of the unmet clinical need, evidence of clinical and cost-effectiveness of laboratory tests, and a managed implementation that takes into account the process change, appropriate resource management, and monitoring of outcomes. The main objectives of this chapter are to elucidate the role of innovation in laboratory medicine, identifying its main issues and the barriers it faces; to define a value proposition for laboratory tests and to point out several outcome measures that can be adopted in laboratory medicine.


Sign in / Sign up

Export Citation Format

Share Document